Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Detailed Analysis Report 2018-2023

Published: Jan, 2018 | Pages: 116 | Publisher: Detailed-Analysis Research (DAR)
Industry: Medical Devices | Report Format: Electronic (PDF)

This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Benign Prostatic Hyperplasia (BPH) Treatment Devices industry.

This report splits Benign Prostatic Hyperplasia (BPH) Treatment Devices market by Procedure Type, which covers the history data information from 2013 to 2017 and forecast from 2018 to 2023.

This report focuses Global market, it covers details as following:

Major Companies
    Endo International (US)
    Karl Storz (Germany)
    Medtronic (US)
    Siemens (Germany)
    Lumenis (Israel)
    Olympus (Japan)
    Urologix (US)
    NeoTract (US)
    Boston Scientific (US)
    Urotech (Germany)
    Toshiba (Japan)
    Baxter International (US)

Main Regions
    North America
        United States
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main Product Type
Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, by Procedure Type
    Laser Based Procedure
    Other Energy Based Procedure
Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, by

Main Applications
    Hospitals
    Ambulatory Surgical Centers
    Specialty Clinics
    Others

 Table of Contents

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Detailed Analysis Report 2018-2023
Chapter One Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Overview
    1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Sales Volume Revenue and Price 2013-2023
    1.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices, by Procedure Type 2013-2023
        1.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Procedure Type 2013-2023
        1.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Procedure Type 2013-2023
        1.2.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Procedure Type 2013-2023
        1.2.4 Laser Based Procedure
        1.2.5 Other Energy Based Procedure
    1.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices, by  2013-2023
        1.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by  2013-2023
        1.3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by  2013-2023
        1.3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by  2013-2023
        1.3.4 
        1.3.5 

Chapter Two Benign Prostatic Hyperplasia (BPH) Treatment Devices by Regions 2013-2018
    2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions 2013-2018
    2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions 2013-2018
    2.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Regions 2013-2018
    2.4 North America
        2.4.1 United States
        2.4.2 Canada
    2.5 Latin America
        2.5.1 Mexico
        2.5.2 Brazil
        2.5.3 Argentina
        2.5.4 Others in Latin America
    2.6 Europe
        2.6.1 Germany
        2.6.2 United Kingdom
        2.6.3 France
        2.6.4 Italy
        2.6.5 Spain
        2.6.6 Russia
        2.6.7 Netherland
        2.6.8 Others in Europe
    2.7 Asia & Pacific
        2.7.1 China
        2.7.2 Japan
        2.7.3 India
        2.7.4 Korea
        2.7.5 Australia
        2.7.6 Southeast Asia
            2.7.6.1 Indonesia
            2.7.6.2 Thailand
            2.7.6.3 Philippines
            2.7.6.4 Vietnam
            2.7.6.5 Singapore
            2.7.6.6 Malaysia
            2.7.6.7 Others in Southeast Asia
    2.8 Africa & Middle East
        2.8.1 South Africa
        2.8.2 Egypt
        2.8.3 Turkey
        2.8.4 Saudi Arabia
        2.8.5 Iran
        2.8.6 Others in Africa & Middle East

Chapter Three Benign Prostatic Hyperplasia (BPH) Treatment Devices by Players 2013-2018
    3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Players 2013-2018
    3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Players 2013-2018
    3.3 Global Top Players Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Product Model and Market Performance
    3.4 Global Top Players Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Target Consumers and Market Performance

Chapter Four Benign Prostatic Hyperplasia (BPH) Treatment Devices by Consumer 2013-2018
    4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Consumer 2013-2018
    4.2 Hospitals
    4.3 Ambulatory Surgical Centers
    4.4 Specialty Clinics
    4.5 Others
    4.6 Consuming Habit and Preference

Chapter Five Global Top Players Profile
    5.1 Endo International (US)
        5.1.1 Endo International (US) Company Details and Competitors
        5.1.2 Endo International (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
        5.1.3 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
        5.1.4 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
    5.2 Karl Storz (Germany)
        5.2.1 Karl Storz (Germany) Company Details and Competitors
        5.2.2 Karl Storz (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
        5.2.3 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
        5.2.4 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
    5.3 Medtronic (US)
        5.3.1 Medtronic (US) Company Details and Competitors
        5.3.2 Medtronic (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
        5.3.3 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
        5.3.4 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
    5.4 Siemens (Germany)
        5.4.1 Siemens (Germany) Company Details and Competitors
        5.4.2 Siemens (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
        5.4.3 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
        5.4.4 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
    5.5 Lumenis (Israel)
        5.5.1 Lumenis (Israel) Company Details and Competitors
        5.5.2 Lumenis (Israel) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
        5.5.3 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
        5.5.4 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
    5.6 Olympus (Japan)
        5.6.1 Olympus (Japan) Company Details and Competitors
        5.6.2 Olympus (Japan) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
        5.6.3 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
        5.6.4 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
    5.7 Urologix (US)
        5.7.1 Urologix (US) Company Details and Competitors
        5.7.2 Urologix (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
        5.7.3 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
        5.7.4 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
    5.8 NeoTract (US)
        5.8.1 NeoTract (US) Company Details and Competitors
        5.8.2 NeoTract (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
        5.8.3 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
        5.8.4 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
    5.9 Boston Scientific (US)
        5.9.1 Boston Scientific (US) Company Details and Competitors
        5.9.2 Boston Scientific (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
        5.9.3 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
        5.9.4 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
    5.10 Urotech (Germany)
        5.10.1 Urotech (Germany) Company Details and Competitors
        5.10.2 Urotech (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
        5.10.3 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
        5.10.4 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
    5.11 Toshiba (Japan)
    5.12 Baxter International (US)

Chapter Six Industry Chain and Supply Chain
    6.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry Chain Structure
        6.1.1 R&D
        6.1.2 Raw Materials (Components)
        6.1.3 Manufacturing Plants
        6.1.4 Regional Trading (Import Export and Local Sales)
        6.1.5 Online Sales Channel
        6.1.6 Offline Channel
        6.1.7 End Users
    6.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing
        6.2.1 Key Components
        6.2.2 Assembly Manufacturing
    6.3 Consumer Preference
    6.4 Behavioral Habits
    6.5 Marketing Environment

Chapter Seven Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Sales and Revenue) Forecast (2018-2023)
    7.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Million Units), Revenue (Million USD) Forecast (2018-2023)
    7.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Million Units) Forecast by Regions (2018-2023)
    7.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Million Units) Forecast by Application (2018-2023)
    7.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Million Units) Forecast by Procedure Type (2018-2023)
    7.5 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Million Units) Forecast by  (2018-2023)

Chapter Eight Development Trend and Research Conclusion
    8.1 Development Trend
    8.2 Research Conclusion

Chapter Nine Methodology and Data Source
    9.1 Methodology/Research Approach
        9.1.1 Research Programs/Design
        9.1.2 Market Size Estimation
        9.1.3 Market Breakdown and Data Triangulation
    9.2 Data Source
        9.2.1 Secondary Sources
        9.2.2 Primary Sources
    9.3 Disclaimer

List of Tables and Figures

    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2013-2018)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) and Growth Rate (2013-2018)
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Procedure Type (2013-2018)
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Procedure Type (2013-2018)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Procedure Type in 2017
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Procedure Type (2013-2018)
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Procedure Type (2013-2018)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Procedure Type in 2016
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) by Procedure Type (2013-2018)
    Table Top Players of Laser Based Procedure Benign Prostatic Hyperplasia (BPH) Treatment Devices Products List
    Figure Global Laser Based Procedure Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
    Table Top Players of Other Energy Based Procedure Benign Prostatic Hyperplasia (BPH) Treatment Devices Products List
    Figure Global Other Energy Based Procedure Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by  (2013-2018)
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by  (2013-2018)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by  in 2017
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by  (2013-2018)
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by  (2013-2018)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by  in 2017
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) by  (2013-2018)
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Regions (2013-2018)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions in 2017
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions in 2018
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions (2013-2018)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions in 2017
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions in 2018
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) by Regions (2013-2018)
    Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
    Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
    Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
    Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
    Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
    Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
    Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
    Figure Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
    Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
    Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
    Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
    Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
    Table Asia & Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
    Table Asia & Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
    Table Asia & Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
    Figure Asia & Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
    Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
    Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
    Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
    Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
    Table Africa & Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
    Table Africa & Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
    Table Africa & Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
    Figure Africa & Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Key Players (2013-2018)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Key Players 2017
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Key Players 2018
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Key Players (2013-2018)
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Key Players (2013-2018)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Key Players 2017
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Key Players 2018
    Table Global Top Players Key Product Model and Market Performance
    Table Global Top Players Key Target Consumers and Market Performance
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Consumer (2013-2018)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Consumer (2013-2018)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Consumer in 2017
    Figure Global Hospitals Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
    Figure Global Ambulatory Surgical Centers Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
    Figure Global Specialty Clinics Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
    Figure Global Others Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
    Table Endo International (US) Company Details and Competitors
    Table Endo International (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
    Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
    Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2023)
    Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2023)
    Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2023)
    Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2023)
    Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2023)
    Table Karl Storz (Germany) Company Details and Competitors
    Table Karl Storz (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
    Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
    Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2023)
    Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2023)
    Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2023)
    Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2023)
    Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2023)
    Table Medtronic (US) Company Details and Competitors
    Table Medtronic (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
    Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
    Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2023)
    Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2023)
    Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2023)
    Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2023)
    Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2023)
    Table Siemens (Germany) Company Details and Competitors
    Table Siemens (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
    Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
    Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2023)
    Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2023)
    Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2023)
    Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2023)
    Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2023)
    Table Lumenis (Israel) Company Details and Competitors
    Table Lumenis (Israel) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
    Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
    Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2023)
    Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2023)
    Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2023)
    Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2023)
    Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2023)
    Table Olympus (Japan) Company Details and Competitors
    Table Olympus (Japan) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
    Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
    Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2023)
    Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2023)
    Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2023)
    Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2023)
    Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2023)
    Table Urologix (US) Company Details and Competitors
    Table Urologix (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
    Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
    Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2023)
    Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2023)
    Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2023)
    Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2023)
    Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2023)
    Table NeoTract (US) Company Details and Competitors
    Table NeoTract (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
    Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
    Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2023)
    Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2023)
    Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2023)
    Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2023)
    Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2023)
    Table Boston Scientific (US) Company Details and Competitors
    Table Boston Scientific (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
    Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
    Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2023)
    Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2023)
    Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2023)
    Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2023)
    Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2023)
    Table Urotech (Germany) Company Details and Competitors
    Table Urotech (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
    Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
    Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2023)
    Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2023)
    Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2023)
    Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2023)
    Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2023)
    Table Toshiba (Japan) Company Details and Competitors
    Table Baxter International (US) Company Details and Competitors
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2018-2023)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) Trend Forecast (2018-2023)
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Regions (2018-2023)
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Share Forecast by Regions (2018-2023)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Share Forecast by Regions (2018-2023)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Share Forecast by Regions in 2023
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Application (2018-2023)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by Application (2018-2023)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by Application in 2023
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Procedure Type (2018-2023)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Procedure Type (2018-2023)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by Procedure Type in 2023
    Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by  (2018-2023)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by  (2018-2023)
    Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by  in 2023